Skip to main content Back to Top
Advertisement

11/12/2021

Atracurium Injection

Products Affected - Description

    • Atracurium Besylate injection, Meitheal Pharmaceuticals, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 71288-0702-10
    • Atracurium Besylate injection, Pfizer, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 0040-1105-02
    • Atracurium Besylate injection, Pfizer, 10 mg/mL, 5 mL single dose vial, 10 count, NDC 00409-1109-01

Reason for the Shortage

    • Meitheal has atracurium on shortage due to increased demand.
    • Pfizer has atracurium on shortage due to increased demand.

Available Products

    • Atracurium Besylate injection, Meitheal Pharmaceuticals, 10 mg/mL, 5 mL single dose vial, 10 count, NDC 71288-0701-05

Estimated Resupply Dates

    • Meitheal has atracurium 10 mg/mL 10 mL vials on allocation. Check wholesalers for inventory.
    • Pfizer has atracurium 10 mg/mL 10 mL vials on back order and the company estimates a release date of December 2021. The 5 mL vials are available in limited supply.

Updated

Updated November 12, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 7, 2021 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.